Kaplan Myron 4
4 · CorMedix Inc. · Filed Sep 4, 2020
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Kaplan Myron
Director
Transactions
- Purchase
Common Stock
2020-09-02$4.27/sh+15,300$65,359→ 150,034 total
Holdings
- 15,000
Stock Option (Right to Buy Common Stock)
Exercise: $8.30Exp: 2029-01-10→ Common Stock (15,000 underlying) - 8,000
Stock Option (Right to Buy Common Stock)
Exercise: $11.20Exp: 2027-02-21→ Common Stock (8,000 underlying) - 15,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-02-25→ Common Stock (15,000 underlying) - 8,000
Stock Option (Right to Buy Common Stock)
Exercise: $2.85Exp: 2028-02-16→ Common Stock (8,000 underlying) - 10,000
Stock Option (Right to Buy Common Stock)
Exercise: $21.40Exp: 2026-04-28→ Common Stock (10,000 underlying)
Footnotes (6)
- [F1]This transaction was executed in multiple trades at prices ranging from $4.25 to $4.28. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
- [F3]These options were granted on 01/10/2019. These options are fully vested.
- [F4]These options were granted on 02/16/2018. These options are fully vested.
- [F5]These options were granted on 02/21/2017. These options are fully vested.
- [F6]These options were granted on 4/28/2016. These options are fully vested.